Controlled human-depletion study: healthy male volunteers were hospitalized and fed a semisynthetic, choline-free diet (with 1 week of 500 mg/day choline run-in), then randomized to continued choline (control) or a choline-deficient diet for 3 further weeks. Subjects on the deficient diet developed depleted tissue choline stores and biochemical signs of incipient liver dysfunction (elevated serum aminotransferases), reversible on choline repletion — establishing that choline, not previously classified as essential because the body can synthesize some via de novo phosphatidylcholine synthesis, is conditionally essential in humans when dietary methionine/folate are not in excess.

relevance_note: Foundational primary evidence for choline essentiality and its liver relevance (NAFLD-adjacent endpoint) — the mechanistic basis for why eggs’ choline content is nutritionally consequential rather than incidental.

Depth note: full text paywalled (FASEB J, 1991); extraction rests on the comprehensive abstract (all quantitative results reported there) plus the node’s step-2 method_read.

Methodology

Controlled inpatient depletion-repletion feeding study: healthy male volunteers hospitalized on a semisynthetic diet devoid of choline but with 500 mg/day choline for a 1-week run-in, then randomized to continued choline (control) vs no choline (deficient) for 3 further weeks, with all subjects re-supplemented in week 5. The diet carried adequate but not excess methionine (and folate), so the endogenous methyl-group and de-novo phosphatidylcholine (PEMT) pathways were not artificially starved. Objective biomarkers: plasma/erythrocyte choline and phosphatidylcholine, serum aminotransferases and other liver/renal tests, serum cholesterol.

Results

O-94 - Choline-free diet for 3 weeks depleted plasma choline and phosphatidylcholine ~30% in healthy men

O-94 — Controlled inpatient depletion-repletion design (1 wk 500 mg/day choline run-in, 3 wk deficient vs control, 1 wk repletion). Demonstrates that tissue choline stores deplete on a choline-free diet despite endogenous de novo phosphatidylcholine synthesis. See

Methodology

Controlled inpatient depletion-repletion feeding study: healthy male volunteers hospitalized on a semisynthetic diet devoid of choline but with 500 mg/day choline for a 1-week run-in, then randomized to continued choline (control) vs no choline (deficient) for 3 further weeks, with all subjects re-supplemented in week 5. The diet carried adequate but not excess methionine (and folate), so the endogenous methyl-group and de-novo phosphatidylcholine (PEMT) pathways were not artificially starved. Objective biomarkers: plasma/erythrocyte choline and phosphatidylcholine, serum aminotransferases and other liver/renal tests, serum cholesterol.

Link to original

Link to original

O-95 - Choline deficiency raised serum ALT (0.42 to 0.62 mukat-L) in deficient men only, other liver-renal tests unchanged

O-95 — Elevated aminotransferase indicates hepatocellular stress; the isolated ALT rise (with other tests normal) marks incipient, reversible liver dysfunction attributable specifically to choline removal.

Link to original

O-96 - Choline deficiency lowered serum cholesterol ~15% in deficient men only

O-96 — Consistent with choline/phosphatidylcholine’s role in hepatic VLDL assembly and lipid export; a mechanistic link between choline status and circulating lipids.

Link to original

Discussion

H-39 - Choline is an essential nutrient for humans when dietary methionine and folate are not in excess

H-39 — At the time a novel claim (choline was not classified essential in humans); now established (an Adequate Intake was set in 1998). Establishes that eggs’ high choline content is nutritionally consequential rather than incidental.

Link to original

A-33 - Reversible depletion plus liver dysfunction on choline removal from an otherwise-complete diet meets the criterion for essentiality

Reasoning (A-33): The operational criterion for classifying a nutrient as essential is: when it (and only it) is removed from an otherwise-complete diet, a specific deficiency sign develops that is corrected by restoring that nutrient. The design isolates choline as the sole manipulated variable - a semisynthetic diet identical between arms except for choline, with adequate methionine and folate so that the methyl-group and de-novo-phosphatidylcholine (PEMT) pathways are not artificially starved. Under that control, the deficient arm alone shows (1) ~30% depletion of plasma choline and phosphatidylcholine and (2) a rising ALT indicating incipient hepatocellular dysfunction, while every other liver/renal test and the control arm stay flat; both abnormalities reverse when choline is returned in week 5. The counterfactual is supplied by the concurrent control group, so the changes cannot be attributed to hospitalization or the semisynthetic diet per se. The crucial subtlety the argument turns on: humans do synthesize choline de novo via PEMT, which is why choline had not been classified essential; but this experiment shows that under normal (non-excess) methionine/folate that endogenous route is insufficient to prevent deficiency, so intake is still required. Removal-plus-reversal with a matched control is a strong (near-deductive within the essentiality framework) warrant for the essentiality conclusion; the main limitation is the small, short-term, male-only sample, which bounds generalization of thresholds but not the qualitative essentiality claim.

Validity verdict (step 6)

status: approved, checked. Reconstruction: the step is subsumption of the experiment under an operational criterion — “removed as the sole variable from an otherwise-complete diet → a specific deficiency sign appears → it reverses on repletion, with a concurrent control ruling out non-specific causes ⇒ essential.” Load-bearing implicit premises surfaced: (i) the ALT rise (0.42→0.62 µkat/L, deficient arm only, reversing on repletion) counts as a genuine deficiency sign of hepatocellular dysfunction rather than a bare biomarker wobble, and (ii) adequate (non-excess) methionine/folate means the PEMT/de-novo route was not artificially starved, so its insufficiency is real, not an artifact of methyl-donor deprivation. Conditional on the premises, the subsumption is near-deductive within the essentiality framework and traces cleanly. Undercutting-defeater probe: candidate defeater is “hospitalization/semisynthetic-diet per se caused the change” — blocked by the concurrent choline-continued control staying flat; a second candidate is “one reversible enzyme elevation is too thin to be a deficiency sign” — this attacks premise (i) (truth), not the inference, so it is priced later as a likelihood, not a validity failure here. No weaker conclusion is forced; qualitative essentiality (scoped to non-excess methyl donors, matching H-39) holds as stated. checked: the criterion and its application are elementary, traced without leaning on source authority.

Link to original